Chiome Bioscience Inc
TSE:4583
Chiome Bioscience Inc
Net Income (Common)
Chiome Bioscience Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Chiome Bioscience Inc
TSE:4583
|
Net Income (Common)
-¥1.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-7%
|
CMIC Holdings Co Ltd
TSE:2309
|
Net Income (Common)
¥5.3B
|
CAGR 3-Years
50%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
|
Medinet Co Ltd
TSE:2370
|
Net Income (Common)
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
CellSource Co Ltd
TSE:4880
|
Net Income (Common)
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Net Income (Common)
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Net Income (Common)
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Chiome Bioscience Inc's Net Income (Common)?
Net Income (Common)
-1.2B
JPY
Based on the financial report for Dec 31, 2023, Chiome Bioscience Inc's Net Income (Common) amounts to -1.2B JPY.
What is Chiome Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-7%
Over the last year, the Net Income (Common) growth was 2%. The average annual Net Income (Common) growth rates for Chiome Bioscience Inc have been 2% over the past three years , 4% over the past five years , and -7% over the past ten years .